Lv1
50 积分 2023-03-01 加入
[New guidelines to evaluate the response to treatment in solid tumors]
3个月前
已关闭
RECIST 1.1—Update and clarification: From the RECIST committee
3个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
6个月前
已完结
Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC
7个月前
已完结
皖公网安备34019202002308
